OrthoPediatrics Corp Pre-Tax Income
OrthoPediatrics Corp (KIDS) reported Pre-Tax Income of -$6.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-05
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$6.93M.
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$10.86M.
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$9.76M.
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$11.90M.
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$39.19M.
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$41.93M.
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$21.31M.
- OrthoPediatrics Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$3.69M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.93M 10-Q · filed 2026-08-05 | -$17.79M 10-Q · filed 2026-08-05 | -$27.55M derived: sum of 3 quarters · filed 2026-08-05 | -$39.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$10.86M 10-Q · filed 2026-05-01 | -$20.62M derived: sum of 2 quarters · filed 2026-05-01 | -$32.52M derived: sum of 3 quarters · filed 2026-05-01 | -$39.58M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$21.66M derived: sum of 2 quarters · filed 2026-03-04 | -$28.73M derived: sum of 3 quarters · filed 2026-08-05 | -$39.19M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$11.90M 10-Q · filed 2025-10-29 | -$18.96M derived: sum of 2 quarters · filed 2026-08-05 | -$29.43M 10-Q · filed 2025-10-29 | -$45.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$7.06M 10-Q · filed 2026-08-05 | -$17.53M 10-Q · filed 2026-08-05 | -$33.94M derived: sum of 3 quarters · filed 2026-08-05 | -$43.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$10.46M 10-Q · filed 2026-05-01 | -$26.87M derived: sum of 2 quarters · filed 2026-05-01 | -$36.01M derived: sum of 3 quarters · filed 2026-05-01 | -$42.06M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$16.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$25.55M derived: sum of 2 quarters · filed 2026-03-04 | -$31.59M derived: sum of 3 quarters · filed 2026-03-04 | -$41.93M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$9.14M 10-Q · filed 2025-10-29 | -$15.18M derived: sum of 2 quarters · filed 2025-10-29 | -$25.52M 10-Q · filed 2025-10-29 | -$32.42M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | -$6.05M 10-Q · filed 2025-08-06 | -$16.38M 10-Q · filed 2025-08-06 | -$23.29M derived: sum of 3 quarters · filed 2026-03-04 | -$27.03M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | -$10.34M 10-Q · filed 2025-05-08 | -$17.24M derived: sum of 2 quarters · filed 2026-03-04 | -$20.98M derived: sum of 3 quarters · filed 2026-03-04 | -$24.27M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$10.64M derived: sum of 2 quarters · filed 2026-03-04 | -$13.93M derived: sum of 3 quarters · filed 2026-03-04 | -$21.31M 10-K · filed 2026-03-04 |
| 2023-09-30 | -$3.74M 10-Q · filed 2024-11-07 | -$7.03M derived: sum of 2 quarters · filed 2024-11-07 | -$14.41M 10-Q · filed 2024-11-07 | -$22.30M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | -$3.29M 10-Q · filed 2024-08-06 | -$10.67M 10-Q · filed 2024-08-06 | -$18.56M derived: sum of 3 quarters · filed 2025-03-05 | -$4.17M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | -$7.38M 10-Q · filed 2024-05-07 | -$15.28M derived: sum of 2 quarters · filed 2025-03-05 | -$880.00K derived: sum of 3 quarters · filed 2025-03-05 | -$1.65M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | -$7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $6.50M derived: sum of 2 quarters · filed 2025-03-05 | $5.73M derived: sum of 3 quarters · filed 2025-03-05 | -$3.69M 10-K · filed 2025-03-05 |
| 2022-09-30 | $14.40M 10-Q · filed 2023-11-07 | $13.62M derived: sum of 2 quarters · filed 2023-11-07 | $4.21M 10-Q · filed 2023-11-07 | $4.04M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$772.00K 10-Q · filed 2023-08-01 | -$10.19M 10-Q · filed 2023-08-01 | -$10.36M derived: sum of 3 quarters · filed 2023-08-01 | -$12.84M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | -$9.42M 10-Q · filed 2023-05-02 | -$9.58M derived: sum of 2 quarters · filed 2023-05-02 | -$12.07M derived: sum of 3 quarters · filed 2023-05-02 | -$16.11M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | -$166.00K 10-K · filed 2022-03-03 | -$2.65M derived: sum of 2 quarters · filed 2022-11-01 | -$6.70M derived: sum of 3 quarters · filed 2022-11-01 | -$17.39M 10-K · filed 2024-03-08 |
| 2021-09-30 | -$2.49M 10-Q · filed 2022-11-01 | -$6.53M derived: sum of 2 quarters · filed 2022-11-01 | -$17.22M 10-Q · filed 2022-11-01 | -$31.96M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | -$4.04M 10-Q · filed 2022-08-04 | -$14.73M 10-Q · filed 2022-08-04 | -$29.47M derived: sum of 3 quarters · filed 2022-08-04 | -$34.01M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$10.69M 10-Q · filed 2022-05-05 | -$25.43M derived: sum of 2 quarters · filed 2022-05-05 | -$29.97M derived: sum of 3 quarters · filed 2022-05-05 | -$39.41M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$14.74M 10-K · filed 2022-03-03 | -$19.27M derived: sum of 2 quarters · filed 2022-03-03 | -$28.72M derived: sum of 3 quarters · filed 2022-03-03 | -$33.67M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$4.54M 10-K · filed 2022-03-03 | -$13.99M derived: sum of 2 quarters · filed 2022-03-03 | -$18.93M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$9.45M 10-K · filed 2022-03-03 | -$14.39M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$4.95M 10-K · filed 2022-03-03 | |||
| 2019-12-31 | -$12.69M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |